StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
74
This month
3
This week
1
This year
8
Yesterday
1
Publishing Date
2024 - 04 - 01
2
2024 - 02 - 01
2
2023 - 11 - 01
1
2023 - 09 - 26
1
2023 - 09 - 12
1
2023 - 09 - 07
1
2023 - 08 - 30
1
2023 - 08 - 08
1
2023 - 07 - 28
1
2023 - 07 - 24
1
2023 - 07 - 19
1
2023 - 07 - 07
1
2023 - 07 - 03
1
2023 - 06 - 09
1
2023 - 06 - 01
2
2023 - 05 - 22
1
2023 - 05 - 16
1
2023 - 05 - 11
2
2023 - 04 - 10
1
2023 - 03 - 29
1
2023 - 03 - 24
1
2023 - 03 - 16
1
2023 - 03 - 14
1
2022 - 11 - 14
1
2022 - 11 - 03
2
2022 - 10 - 19
1
2022 - 10 - 04
2
2022 - 09 - 22
1
2022 - 09 - 13
1
2022 - 08 - 11
1
2022 - 07 - 20
1
2022 - 06 - 27
1
2022 - 06 - 06
1
2022 - 05 - 19
1
2022 - 05 - 17
1
2022 - 05 - 13
1
2022 - 05 - 04
1
2022 - 04 - 29
2
2022 - 03 - 31
1
2022 - 03 - 28
1
2022 - 03 - 14
1
2021 - 12 - 22
1
2021 - 12 - 17
1
2021 - 11 - 16
1
2021 - 11 - 15
1
2021 - 10 - 21
1
2021 - 10 - 13
1
2021 - 09 - 07
1
2021 - 08 - 10
1
2021 - 07 - 28
1
2021 - 06 - 02
1
2021 - 05 - 26
1
2021 - 05 - 25
1
2021 - 05 - 18
1
2021 - 03 - 24
1
2020 - 11 - 09
1
2020 - 09 - 28
1
2020 - 09 - 08
1
2020 - 08 - 10
1
2020 - 05 - 06
1
Sector
Consumer non-durables
1
Health technology
74
N/a
1
Tags
Aav204
1
Aav9
3
America
2
Application
5
Aβos
5
Biomidwest
3
Calendar of events
2
Cell
2
Clinical-trials-phase-iii
4
Company announcement
5
Conference
10
Direct
2
Directors and officers
4
Disease
4
Drug
2
Earnings
2
Earnings releases and operating results
3
Eb-101
10
Employee
7
Enroll
2
Events
7
Fda
7
Financial
7
Financial results
4
Gene therapies
8
Gene therapy
11
Genetic
2
Granted
2
Grants
8
Growth
3
Health
2
International
2
License
7
Market
8
Meeting
6
N/a
73
Nasdaq
11
Offering
3
People
3
Pharm-country
5
Phase 1
2
Phase 3
5
Positive
3
Preclinical
2
Presentation
8
Program
3
Rare
2
Report
3
Research
5
Results
19
Review
2
Study
6
Submission
2
Syndros
2
Therapeutics
74
Therapy
21
Topline
2
Treatment
4
Update
6
Year
2
Entities
Abbvie inc.
88
Abeona therapeutics inc.
74
Adc therapeutics sa
82
Agile therapeutics, inc.
61
Akebia therapeutics, inc.
67
Akero therapeutics, inc.
63
Aldeyra therapeutics, inc.
58
Aligos therapeutics, inc.
57
Allogene therapeutics, inc.
86
Altamira therapeutics ltd
55
Alterity therapeutics limited
74
Amgen inc.
69
Amicus therapeutics, inc.
56
Amplitude healthcare acquisition corp
59
Aquestive therapeutics, inc.
82
Astrazeneca plc
71
Autolus therapeutics plc
55
Axsome therapeutics, inc.
79
Bioxcel therapeutics, inc.
63
Brainstorm cell therapeutics inc.
57
Cidara therapeutics, inc.
64
Cognition therapeutics inc
80
Crispr therapeutics ag
62
Cytomx therapeutics, inc.
64
Eli lilly and company
139
Fortress biotech, inc.
73
Fulcrum therapeutics, inc.
74
G1 therapeutics, inc.
81
Glaxosmithkline plc
84
Horizon therapeutics public limited company
74
Hoth therapeutics, inc.
68
Inhibikase therapeutics, inc.
66
Intellia therapeutics, inc.
56
Johnson & johnson
186
Kymera therapeutics, inc.
64
Morgan stanley
148
Novartis ag
115
Nurix therapeutics, inc.
61
Omega therapeutics inc
56
Oncternal therapeutics, inc.
57
Orange
66
Outlook therapeutics, inc.
71
Pliant therapeutics, inc.
70
Plus therapeutics, inc.
85
Poseida therapeutics, inc.
60
Ptc therapeutics, inc.
57
Relief therapeutics holding sa
80
Sangamo therapeutics, inc.
55
Sanofi
343
Sarepta therapeutics, inc.
72
Seres therapeutics, inc.
62
Spero therapeutics, inc.
70
Springworks therapeutics, inc.
58
Teva pharmaceutical industries ltd
64
Tg therapeutics, inc.
88
Transcode therapeutics inc
68
Travere therapeutics inc.
79
Tscan therapeutics inc
66
Vivos therapeutics inc
56
Voyager therapeutics, inc.
75
Symbols
ABEO
74
ALLR
1
ATXI
3
BAX
1
BMRN
1
BMY
2
COTY
1
ICPT
1
JNJ
1
KMDA
1
NVO
1
RARE
2
RGNX
1
TEVJF
1
UPYY
2
Exchanges
Nasdaq
74
Nyse
4
Crawled Date
2024 - 04 - 01
2
2024 - 02 - 01
2
2024 - 01 - 08
1
2023 - 12 - 15
1
2023 - 11 - 27
1
2023 - 11 - 13
1
2023 - 11 - 01
1
2023 - 09 - 26
1
2023 - 09 - 12
1
2023 - 09 - 07
1
2023 - 08 - 30
1
2023 - 08 - 08
1
2023 - 07 - 28
1
2023 - 07 - 24
1
2023 - 07 - 19
1
2023 - 07 - 07
1
2023 - 07 - 03
1
2023 - 06 - 09
1
2023 - 06 - 01
2
2023 - 05 - 22
1
2023 - 05 - 16
1
2023 - 05 - 11
2
2023 - 04 - 10
1
2023 - 03 - 29
1
2023 - 03 - 24
1
2023 - 03 - 16
1
2023 - 03 - 14
1
2022 - 11 - 14
1
2022 - 11 - 03
2
2022 - 10 - 19
1
2022 - 10 - 04
2
2022 - 09 - 22
1
2022 - 09 - 13
1
2022 - 08 - 11
1
2022 - 07 - 20
1
2022 - 06 - 27
1
2022 - 06 - 06
1
2022 - 05 - 19
1
2022 - 05 - 17
1
2022 - 05 - 13
1
2022 - 05 - 04
1
2022 - 04 - 29
2
2022 - 03 - 31
1
2022 - 03 - 28
1
2022 - 03 - 14
1
2021 - 12 - 22
1
2021 - 12 - 17
1
2021 - 11 - 16
1
2021 - 11 - 15
1
2021 - 10 - 21
1
2021 - 10 - 13
1
2021 - 09 - 07
1
2021 - 08 - 10
1
2021 - 07 - 28
1
2021 - 06 - 02
1
2021 - 05 - 26
1
2021 - 05 - 25
1
2021 - 05 - 18
1
2021 - 03 - 24
1
2020 - 12 - 03
5
Crawled Time
10:00
1
11:00
2
12:00
34
12:20
7
12:30
10
13:00
6
14:00
1
15:00
1
15:27
4
15:28
1
17:00
3
20:00
2
21:00
2
Source
www.biospace.com
21
www.globenewswire.com
52
www.prnewswire.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Therapeutics
entities :
Abeona therapeutics inc.
save search
Abeona Therapeutics Provides Regulatory Update on Pz-cel
Published:
2024-04-22
(Crawled : 20:00)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
Email alert
Add to watchlist
update
therapeutics
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - April 1, 2024
Published:
2024-04-01
(Crawled : 17:00)
- biospace.com/
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
0.75%
|
O:
-1.16%
H:
7.48%
C:
6.93%
nasdaq
grants
therapeutics
employee
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published:
2024-04-01
(Crawled : 12:30)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
0.75%
|
O:
-1.16%
H:
7.48%
C:
6.93%
nasdaq
grants
therapeutics
employee
Abeona Therapeutics Reports Full Year 2023 Financial Results and Announces Completion of FDA Inspections
Published:
2024-03-18
(Crawled : 12:00)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
-9.86%
|
O:
-7.65%
H:
0.0%
C:
0.0%
fda
year
therapeutics
financial
results
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published:
2024-03-05
(Crawled : 12:30)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
-8.23%
|
O:
-4.86%
H:
0.0%
C:
0.0%
nasdaq
grants
therapeutics
employee
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published:
2024-02-01
(Crawled : 21:00)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
68.61%
|
O:
-2.86%
H:
5.42%
C:
4.25%
nasdaq
grants
therapeutics
employee
Abeona Therapeutics Announces Progress Update on Pz-cel Biologics License Application (BLA)
Published:
2024-02-01
(Crawled : 12:30)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
66.7%
|
O:
-1.13%
H:
0.0%
C:
0.0%
license
update
application
therapeutics
Abeona Therapeutics Announces $50 Million Credit Facility
Published:
2024-01-08
(Crawled : 12:30)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
27.01%
|
O:
-3.19%
H:
4.37%
C:
4.1%
million
therapeutics
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published:
2023-12-15
(Crawled : 12:30)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
55.27%
|
O:
0.63%
H:
0.0%
C:
0.0%
nasdaq
grants
therapeutics
employee
Abeona Therapeutics Announces FDA Accepts and Grants Priority Review for Pz-cel Biologics License Application (BLA)
Published:
2023-11-27
(Crawled : 12:30)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
77.14%
|
O:
10.71%
H:
16.96%
C:
4.57%
fda
license
review
application
grants
therapeutics
Abeona Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Developments
Published:
2023-11-13
(Crawled : 12:30)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
82.63%
|
O:
2.98%
H:
8.43%
C:
8.43%
therapeutics
financial
results
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Published:
2023-11-01
(Crawled : 12:00)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
90.67%
|
O:
-0.78%
H:
1.31%
C:
0.0%
nasdaq
grants
therapeutics
employee
Abeona Therapeutics Submits Biologics License Application to U.S. FDA Seeking Priority Review and Approval of EB-101 for the Treatment of Patients with Recessive Dystrophic Epidermolysis Bullosa
Published:
2023-09-26
(Crawled : 12:00)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
99.46%
|
O:
-0.27%
H:
19.29%
C:
9.24%
eb-101
fda
license
approval
review
treatment
application
therapeutics
Abeona Therapeutics Appoints Madhav Vasanthavada, Ph.D., M.B.A. as Chief Commercial Officer
Published:
2023-09-12
(Crawled : 12:00)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
82.63%
|
O:
7.69%
H:
1.38%
C:
-3.46%
commercial
therapeutics
Abeona Therapeutics Announces Participation in Upcoming Investor Conferences
Published:
2023-09-07
(Crawled : 12:00)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
77.99%
|
O:
-3.51%
H:
1.25%
C:
0.5%
therapeutics
Abeona Therapeutics Announces Positive Pre-BLA Meeting with FDA for EB-101 and Plans for BLA Submission
Published:
2023-08-30
(Crawled : 12:00)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
81.73%
|
O:
1.48%
H:
9.49%
C:
5.6%
eb-101
fda
positive
meeting
therapeutics
submission
Abeona Therapeutics Reports Second Quarter 2023 Financial Results
Published:
2023-08-08
(Crawled : 12:00)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
145.33%
|
O:
0.0%
H:
0.67%
C:
-0.67%
therapeutics
financial
results
Abeona Therapeutics Announces Submission of Briefing Package for Pre-Biologics License Application (BLA) Meeting with FDA in August 2023
Published:
2023-07-28
(Crawled : 12:00)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
118.4%
|
O:
0.89%
H:
5.88%
C:
3.82%
fda
license
meeting
application
therapeutics
submission
Allarity Therapeutics Strengthens Board of Directors with Appointment of Three Accomplished Biotechnology Executives
Published:
2023-07-24
(Crawled : 10:00)
- globenewswire.com
ALLR
|
$1.47
3.52%
680K
|
n/a
|
-52.19%
|
O:
0.34%
H:
1.01%
C:
-3.02%
JNJ
|
News
|
$150.09
0.65%
3.9M
|
Health Technology
|
-12.38%
|
O:
0.77%
H:
1.35%
C:
-0.24%
ICPT
|
$19.0
-0.05%
4M
|
Health Technology
|
81.85%
|
O:
0.29%
H:
0.32%
C:
-1.53%
ATXI
|
$0.1301
220K
|
Health Technology
|
-88.6%
|
O:
-1.75%
H:
3.57%
C:
-2.75%
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
96.27%
|
O:
-0.53%
H:
0.27%
C:
-3.49%
therapeutics
Abeona Therapeutics Joins Rare Disease Company Coalition
Published:
2023-07-19
(Crawled : 12:00)
- globenewswire.com
ABEO
|
News
|
$3.395
-53.87%
4.4M
|
Health Technology
|
88.72%
|
O:
-0.26%
H:
0.56%
C:
-2.57%
rare
disease
therapeutics
← Previous
1
2
3
4
Next →
Gainers vs Losers
87%
13%
Top 10 Gainers
MTTR
|
News
M
|
$4.64
166.67%
18M
|
AGBA
|
$2.74
119.2%
52M
|
Finance
CZOO
|
$9.07
81.76%
22M
|
EDBL
|
News
|
$6.56
74.47%
1.8M
|
OPRT
|
News
|
$3.37
49.78%
8.9M
|
Finance
MTC
|
$2.14
37.18%
4.9M
|
Technology Services
VNRX
|
$0.7945
32.42%
3.1M
|
Health Technology
MLEC
|
$1.79
27.86%
2.6M
|
n/a
BTCM
|
$3.45
27.78%
640K
|
Arts, Entertainment, and Recrea...
PALI
|
$6.29
27.59%
22M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.